相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Unexpected Effect of Rifampin on the Pharmacokinetics of Linezolid: In Silico and In Vitro Approaches to Explain Its Mechanism
Kuan Gandelman et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2011)
Bioavailability Considerations in Evaluating Drug-Drug Interactions Using the Population Pharmacokinetic Approach
John Z. Duan et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2011)
Effect of Obesity on the Pharmacokinetics of Drugs in Humans
Michael J. Hanley et al.
CLINICAL PHARMACOKINETICS (2010)
Predictions of Metabolic Drug-Drug Interactions Using Physiologically Based Modelling Two Cytochrome P450 3A4 Substrates Coadministered with Ketoconazole or Verapamil
Nathalie Perdaems et al.
CLINICAL PHARMACOKINETICS (2010)
A Semi-Mechanistic Model to Predict the Effects of Liver Cirrhosis on Drug Clearance
Trevor N. Johnson et al.
CLINICAL PHARMACOKINETICS (2010)
Applying Physiological and Biochemical Concepts to Optimize Biological Drug Development
P. J. Lowe
CLINICAL PHARMACOLOGY & THERAPEUTICS (2010)
Inflammation: Planning for a Source of Pharmacokinetic/Pharmacodynamic Variability in Translational Studies
V. D. Schmith et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2010)
Therapeutic Protein-Drug Interactions and Implications for Drug Development
S-M Huang et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2010)
Dosing in Children
N. Holford
CLINICAL PHARMACOLOGY & THERAPEUTICS (2010)
Identification of Cytochrome P450 Isoforms Involved in the Metabolism of Paroxetine and Estimation of Their Importance for Human Paroxetine Metabolism Using a Population-Based Simulator
Jakob Jornil et al.
DRUG METABOLISM AND DISPOSITION (2010)
Quantitative Prediction of Intestinal Metabolism in Humans from a Simplified Intestinal Availability Model and Empirical Scaling Factor
Keitaro Kadono et al.
DRUG METABOLISM AND DISPOSITION (2010)
Confidence Assessment of the Simcyp Time-Based Approach and a Static Mathematical Model in Predicting Clinical Drug-Drug Interactions for Mechanism-Based CYP3A Inhibitors
Ying-Hong Wang
DRUG METABOLISM AND DISPOSITION (2010)
Prediction of Human Intestinal First-Pass Metabolism of 25 CYP3A Substrates from In Vitro Clearance and Permeability Data
Michael Gertz et al.
DRUG METABOLISM AND DISPOSITION (2010)
Theoretical Considerations on Quantitative Prediction of Drug-Drug Interactions
Akihiro Hisaka et al.
DRUG METABOLISM AND PHARMACOKINETICS (2010)
Pharmacokinetic modeling of the hepatobiliary transport mediated by cooperation of uptake and efflux transporters
Hiroyuki Kusuhara et al.
DRUG METABOLISM REVIEWS (2010)
In vitro-in vivo extrapolation of zolpidem as a perpetrator of metabolic interactions involving CYP3A
Thomas M. Polasek et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2010)
Physiologically based mechanistic modelling to predict complex drug-drug interactions involving simultaneous competitive and time-dependent enzyme inhibition by parent compound and its metabolite in both liver and gut-The effect of diltiazem on the time-course of exposure to triazolam
Karen Rowland Yeo et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2010)
Physiologically Based Predictions of the Impact of Inhibition of intestinal and Hepatic Metabolism on Human Pharmacokinetics of CYP3A Substrates
Frederique Fenneteau et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2010)
Mechanistic Insight from In Silico Pharmacokinetic Experiments: Roles of P-glycoprotein, Cyp3A4 Enzymes, and Microenvironments
Tai Ning Lam et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
Whole-body physiologically based pharmacokinetic population modelling of oral drug administration: inter-individual variability of cimetidine absorption
Stefan Willmann et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2010)
Membrane transporters in drug development
Kathleen M. Giacomini et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Drug interactions evaluation: An integrated part of risk assessment of therapeutics
Lei Zhang et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2010)
Selective serotonin reuptake inhibitors and breast cancer mortality in women receiving tamoxifen: a population based cohort study
Catherine M. Kelly et al.
BMJ-BRITISH MEDICAL JOURNAL (2010)
Predicting Pharmacokinetics of Drugs Using Physiologically Based Modeling-Application to Food Effects
N. Parrott et al.
AAPS JOURNAL (2009)
Simulations of the Nonlinear Dose Dependence for Substrates of Influx and Efflux Transporters in the Human Intestine
Michael B. Bolger et al.
AAPS JOURNAL (2009)
Mechanistic Approaches to Predicting Oral Drug Absorption
Weili Huang et al.
AAPS JOURNAL (2009)
Prediction of Hepatic Clearance in Human From In Vitro Data for Successful Drug Development
Masato Chiba et al.
AAPS JOURNAL (2009)
Predicting Drug-Drug Interactions: An FDA Perspective
Lei Zhang et al.
AAPS JOURNAL (2009)
Modelling and PBPK Simulation in Drug Discovery
Hannah M. Jones et al.
AAPS JOURNAL (2009)
Prediction of Modified Release Pharmacokinetics and Pharmacodynamics from In Vitro, Immediate Release, and Intravenous Data
Viera Lukacova et al.
AAPS JOURNAL (2009)
Population-Based Mechanistic Prediction of Oral Drug Absorption
Masoud Jamei et al.
AAPS JOURNAL (2009)
Proposals for model-based paediatric medicinal development within the current European Union regulatory framework
Efthymios Manolis et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2009)
A population-based study of the drug interaction between proton pump inhibitors and clopidogrel
David N. Juurlink et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2009)
Prediction of Pharmacokinetic Profile of Valsartan in Humans Based on in vitro Uptake-Transport Data
Agnes Poirier et al.
CHEMISTRY & BIODIVERSITY (2009)
Methodological Uncertainty in Quantitative Prediction of Human Hepatic Clearance from In Vitro Experimental Systems
D. Hallifax et al.
CURRENT DRUG METABOLISM (2009)
Design and Application of Microfluidic Systems for In Vitro Pharmacokinetic Evaluation of Drug Candidates
T. J. Maguire et al.
CURRENT DRUG METABOLISM (2009)
Towards a Quantitative Framework for the Prediction of DDIs Arising from Cytochrome P450 Induction
L. M. Almond et al.
CURRENT DRUG METABOLISM (2009)
Prediction of Human Drug-Drug Interactions from Time-Dependent Inactivation of CYP3A4 in Primary Hepatocytes Using a Population-Based Simulator
Lilly Xu et al.
DRUG METABOLISM AND DISPOSITION (2009)
Quantitative Prediction of in Vivo Profiles of CYP3A4 Induction in Humans from in Vitro Results with a Reporter Gene Assay
Masanari Kozawa et al.
DRUG METABOLISM AND DISPOSITION (2009)
Semiphysiologically Based Pharmacokinetic Models for the Inhibition of Midazolam Clearance by Diltiazem and Its Major Metabolite
Xin Zhang et al.
DRUG METABOLISM AND DISPOSITION (2009)
In Vitro and in Vivo Induction of Cytochrome P450: A Survey of the Current Practices and Recommendations: A Pharmaceutical Research and Manufacturers of America Perspective
Valeria Chu et al.
DRUG METABOLISM AND DISPOSITION (2009)
The Conduct of in Vitro Studies to Address Time-Dependent Inhibition of Drug-Metabolizing Enzymes: A Perspective of the Pharmaceutical Research and Manufacturers of America
Scott W. Grimm et al.
DRUG METABOLISM AND DISPOSITION (2009)
Comparison of Different Algorithms for Predicting Clinical Drug-Drug Interactions, Based on the Use of CYP3A4 in Vitro Data: Predictions of Compounds as Precipitants of Interaction
Odette A. Fahmi et al.
DRUG METABOLISM AND DISPOSITION (2009)
In vitro-in vivo Extrapolation of Transporter-mediated Clearance in the Liver and Kidney
Hiroyuki Kusuhara et al.
DRUG METABOLISM AND PHARMACOKINETICS (2009)
A Framework for Assessing Inter-individual Variability in Pharmacokinetics Using Virtual Human Populations and Integrating General Knowledge of Physical Chemistry, Biology, Anatomy, Physiology and Genetics: A Tale of 'Bottom-Up' vs 'Top-Down' Recognition of Covariates
Masoud Jamei et al.
DRUG METABOLISM AND PHARMACOKINETICS (2009)
Physiologically based pharmacokinetics (PBPK)
Pascal Espie et al.
DRUG METABOLISM REVIEWS (2009)
Assessment of inter-individual variability in predicted phenytoin clearance
Thomas M. Polasek et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2009)
Computer simulations using GastroPlus™ to justify a biowaiver for etoricoxib solid oral drug products
Arthur Okumu et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2009)
Human clearance prediction: shifting the paradigm
Thierry Lave et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2009)
The Simcyp® Population-based ADME Simulator
Masoud Jamei et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2009)
Introduction to computational oral absorption simulation
Kiyohiko Sugano
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2009)
Quantitative Evaluation of Pharmacokinetic Inhibition of CYP3A Substrates by Ketoconazole: A Simulation Study
Ping Zhao et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2009)
The Need for Multiple Doses of 400 mg Ketoconazole as a Precipitant Inhibitor of a CYP3A Substrate in an In Vivo Drug-Drug Interaction Study Response
Shiew-Mei Huang et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2009)
Methodology for Development of a Physiological Model Incorporating CYP3A and P-Glycoprotein for the Prediction of Intestinal Drug Absorption
Raj Badhan et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2009)
Development of a Novel Method for Predicting Human Volume of Distribution at Steady-State of Basic Drugs and Comparative Assessment With Existing Methods
Patrick Poulin et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2009)
Assessing drug distribution in tissues expressing P-glycoprotein using physiologically based pharmacokinetic modeling: identification of important model parameters through global sensitivity analysis
Frederique Fenneteau et al.
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2009)
Prediction of pharmacokinetic profile of valsartan in human based on in vitro uptake transport data
Agnes Poirier et al.
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2009)
A method for robust model order reduction in pharmacokinetics
Aristides Dokoumetzidis et al.
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2009)
Physiologically Based Pharmacokinetic Modeling to Predict Transporter-Mediated Clearance and Distribution of Pravastatin in Humans
Takao Watanabe et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
Scientific and Regulatory Perspectives on Metabolizing Enzyme-Transporter Interplay and Its Role in Drug Interactions: Challenges in Predicting Drug Interactions
Lei Zhang et al.
MOLECULAR PHARMACEUTICS (2009)
Impact of Hepatic Uptake Transporters on Pharmacokinetics and Drug-Drug Interactions: Use of Assays and Models for Decision Making in the Pharmaceutical Industry
Mathew G. Soars et al.
MOLECULAR PHARMACEUTICS (2009)
Mechanistic Modeling of Hepatic Transport from Cells to Whole Body: Application to Napsagatran and Fexofenadine
Agnes Poirier et al.
MOLECULAR PHARMACEUTICS (2009)
Interplay of Transporters and Enzymes in Drug and Metabolite Processing
K. Sandy Pang et al.
MOLECULAR PHARMACEUTICS (2009)
Justification of Biowaiver for Carbamazepine, a Low Soluble High Permeable Compound, in Solid Dosage Forms Based on IVIVC and Gastrointestinal Simulation
Ivan Kovacevic et al.
MOLECULAR PHARMACEUTICS (2009)
Prediction of the Effects of Genetic Polymorphism on the Pharmacokinetics of CYP2C9 Substrates from In Vitro Data
Makiko Kusama et al.
PHARMACEUTICAL RESEARCH (2009)
Physiologically-Based PK/PD Modelling of Therapeutic Macromolecules
Peter Thygesen et al.
PHARMACEUTICAL RESEARCH (2009)
Assessing the efficiency of mixed effects modelling in quantifying metabolism based drug-drug interactions: using in vitro data as an aid to assess study power
Trevor N. Johnson et al.
PHARMACEUTICAL STATISTICS (2009)
Prediction of Phase I single-dose pharmacokinetics using recombinant cytochromes P450 and physiologically based modelling
C. R. Gibson et al.
XENOBIOTICA (2009)
Utilization of estimated physicochemical properties as an integrated part of predicting hepatic clearance in the early drug-discovery stage: Impact of plasma and microsomal binding
C. Emoto et al.
XENOBIOTICA (2009)
Application of gastrointestinal simulation for extensions for biowaivers of highly permeable compounds
Marija Tubic-Grozdanis et al.
AAPS JOURNAL (2008)
Application of CYP3A4 in vitro data to predict clinical drug-drug interactions;: predictions of compounds as objects of interaction
Kuresh A. Youdim et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2008)
Maraviroc:: in vitro assessment of drug-drug interaction potential
Ruth Hyland et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2008)
Physiology-Based Simulations of a Pathological Condition Prediction of Pharmacokinetics in Patients with Liver Cirrhosis
Andrea N. Edginton et al.
CLINICAL PHARMACOKINETICS (2008)
General framework for the prediction of oral drug interactions caused by CYP3A4 induction from in vivo information
Yoshiyuki Ohno et al.
CLINICAL PHARMACOKINETICS (2008)
Free drug metabolic clearance in elderly people
Jennifer M. Butler et al.
CLINICAL PHARMACOKINETICS (2008)
Emerging evidence of the impact of kidney disease on drug metabolism and transport
T. D. Nolin et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
Monoclonal Antibody Pharmacokinetics and Pharmacodynamics
W. Wang et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
Cytochrome P450 turnover: Regulation of synthesis and degradation, methods for determining rates, and implications for the prediction of drug interactions
Jiansong Yang et al.
CURRENT DRUG METABOLISM (2008)
Methods for Predicting In Vivo Pharmacokinetics Using Data from In Vitro Assays
J. Brian Houston et al.
CURRENT DRUG METABOLISM (2008)
Predictive physiologically based pharmacokinetic model for antibody-directed enzyme prodrug therapy
Lanyan Fang et al.
DRUG METABOLISM AND DISPOSITION (2008)
Prediction of the pharmacokinetics of atorvastatin, cerivastatin, and indomethacin using kinetic models applied to isolated rat hepatocytes
Stuart W. Paine et al.
DRUG METABOLISM AND DISPOSITION (2008)
The Albumin Effect and drug glucuronidation: Bovine serum albumin and fatty acid-free human serum albumin enhance the glucuronidation of UDP-glucuronosyltransferase (UGT) 1A9 substrates but not UGT1A1 and UGT1A6 activities
Andrew Rowland et al.
DRUG METABOLISM AND DISPOSITION (2008)
Modeling, Prediction, and in Vitro in Vivo Correlation of CYP3A4 Induction
Magang Shou et al.
DRUG METABOLISM AND DISPOSITION (2008)
A combined model for predicting CYP3A4 clinical net drug-drug interaction based on CYP3A4 inhibition, inactivation, and induction determined in vitro
Odette A. Fahmi et al.
DRUG METABOLISM AND DISPOSITION (2008)
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds
R. Scott Obach et al.
DRUG METABOLISM AND DISPOSITION (2008)
Design, Data Analysis, and Simulation of in Vitro Drug Transport Kinetic Experiments Using a Mechanistic in Vitro Model
Agnes Poirier et al.
DRUG METABOLISM AND DISPOSITION (2008)
Physicochemical characterization of five glyburide powders:: A BCS based approach to predict oral absorption
Hai Wei et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2008)
The utility of microdosing over the past 5 years
Graham Lappin et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2008)
Whole body physiologically-based pharmacokinetic models: their use in clinical drug development
Andrea N. Edginton et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2008)
A physiologically based pharmacokinetic (PBPK) model to characterize and predict the disposition of monoclonal antibody CC49 and its single chain Fv constructs
Jasmine P. Davda et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2008)
New era in drug interaction evaluation: US Food and Drug Administration update on CYP enzymes, transporters, and the guidance process
Shiew-Mei Huang et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2008)
Approaches for applications of physiologically based pharmacokinetic models in risk assessment
Chad M. Thompson et al.
JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART B-CRITICAL REVIEWS (2008)
Applications of physiologically based absorption models in drug discovery and development
Neil Parrott et al.
MOLECULAR PHARMACEUTICS (2008)
The quantitative prediction of CYP-mediated drug interaction by physiologically based pharmacokinetic modeling
Motohiro Kato et al.
PHARMACEUTICAL RESEARCH (2008)
Dynamic Dissolution Testing To Establish In Vitro/In Vivo Correlations for Montelukast Sodium, a Poorly Soluble Drug
Arthur Okumu et al.
PHARMACEUTICAL RESEARCH (2008)
Pre-clinical pharmacokinetics of UK-453,061, a novel non-nucleoside reverse transcriptase inhibitor (NNRTI), and use of in silico physiologically based prediction tools to predict the oral pharmacokinetics of UK-453,061 in man
G. Allan et al.
XENOBIOTICA (2008)
Prediction of intestinal first-pass drug metabolism
Jiansong Yang et al.
CURRENT DRUG METABOLISM (2007)
Challenges and opportunities with modelling and simulation in drug discovery and drug development
T. Lave et al.
XENOBIOTICA (2007)
Model-based drug development
R. L. Lalonde et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2007)
The use of mechanistic DM-PK-PD modelling to assess the power of pharmacogenetic studies -: CYP2C9 and warfarin as an example
Gemma L. Dickinson et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2007)
Mechanistic approaches to volume of distribution predictions: Understanding the processes
Trudy Rodgers et al.
PHARMACEUTICAL RESEARCH (2007)
Simulation and prediction of in vivo drug metabolism in human populations from in vitro data
Amin Rostami-Hodjegan et al.
NATURE REVIEWS DRUG DISCOVERY (2007)
Recirculatory pharmacokinetic model of the uptake, distribution, and bioavailability of prochlorperazine administered as a thermally generated aerosol in a single breath to dogs
Michael J. Avram et al.
DRUG METABOLISM AND DISPOSITION (2007)
Scaling factors for the extrapolation of in vivo metabolic drug clearance from in vitro data:: Reaching a consensus on values of human microsomal protein and hepatocellularity per gram of liver
Zoe E. Barter et al.
CURRENT DRUG METABOLISM (2007)
Dynamically simulating the interaction of midazolam and the CYP3A4 inhibitor itraconazole using individual coupled whole-body physiologically-based pharmacokinetic (WB-PBPK) models
Michaela Vossen et al.
THEORETICAL BIOLOGY AND MEDICAL MODELLING (2007)
Development of a physiology-based whole-body population model for assessing the influence of individual variability on the pharmacokinetics of drugs
Stefan Willmann et al.
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2007)
Whole-body physiologically based pharmacokinetic models
Ivan Nestorov
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2007)
The impact of experimental design on assessing mechanism-based inactivation of CYP2D6 by MDMA (Ecstasy)
Linh M. Van et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2006)
Diffusivity and distribution of vinblastine in three-dimensional tumour tissue: Experimental and mathematical modelling
Szabolcs Modok et al.
EUROPEAN JOURNAL OF CANCER (2006)
In silico modeling of non-linear drug absorption for the P-gp substrate talinolol and of consequences for the resulting pharmacodynamic effect
Marija Tubic et al.
PHARMACEUTICAL RESEARCH (2006)
A global examination of allometric scaling for predicting human drug clearance and the prediction of large vertical allometry
Huaidong Tang et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2006)
Integrating in vitro ADMET data through generic physiologically based pharmacokinetic models
David E. Leahy
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2006)
Physiologically based pharmacokinetic modelling 2: Predicting the tissue distribution of acids, very weak bases, neutrals and zwitterions
Trudy Rodgers et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2006)
Binding of drugs to hepatic microsomes: Comment and assessment of current prediction methodology with recommendation for improvement
D Hallifax et al.
DRUG METABOLISM AND DISPOSITION (2006)
The impact of in vitro binding on in vitro -: In vivo extrapolations, projections of metabolic clearance and clinical drug-drug interactions
K Grime et al.
CURRENT DRUG METABOLISM (2006)
A critical evaluation of the experimental design of studies of mechanism based enzyme inhibition, with implications for in vitro-in vivo extrapolation
F Ghanbari et al.
CURRENT DRUG METABOLISM (2006)
Reducing whole body physiologically based pharmacokinetic models using global sensitivity analysis: Diazepam case study
I Gueorguieva et al.
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2006)
The utility of in vitro cytochrome P450 inhibition data in the prediction of drug-drug interactions
RS Obach et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Prediction of the clearance of eleven drugs and associated variability in neonates, infants and children
Trevor N. Johnson et al.
CLINICAL PHARMACOKINETICS (2006)
Predicting pharmacokinetic food effects using biorelevant solubility media and physiologically based modelling
Hannah M. Jones et al.
CLINICAL PHARMACOKINETICS (2006)
A novel strategy for physiologically based predictions of human pharmacokinetics
HM Jones et al.
CLINICAL PHARMACOKINETICS (2006)
A mechanistic approach for the scaling of clearance in children
Andrea N. Edginton et al.
CLINICAL PHARMACOKINETICS (2006)
Development and evaluation of a generic physiologically based pharmacokinetic model for children
Andrea N. Edginton et al.
CLINICAL PHARMACOKINETICS (2006)
Prediction of in vivo drug clearance from in vitro data. I: Impact of inter-individual variability
E. M. Howgate et al.
XENOBIOTICA (2006)
A strategy for preclinical formulation development using GastroPlus (TM) as pharmacokinetic simulation tool and a statistical screening design applied to a dog study
M Kuentz et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2006)
Prediction of time-dependent CYP3A4 drug-drug interactions: Impact of enzyme degradation, parallel elimination pathways, and intestinal inhibition
A Galetin et al.
DRUG METABOLISM AND DISPOSITION (2006)
Application of a generic physiologically based pharmacokinetic model to the estimation of xenobiotic levels in human plasma
FA Brightman et al.
DRUG METABOLISM AND DISPOSITION (2006)
Changes in liver volume from birth to adulthood: A meta-analysis
TN Johnson et al.
LIVER TRANSPLANTATION (2005)
A unified model for predicting human hepatic, metabolic clearance from in vitro intrinsic clearance data in hepatocytes and microsomes
RJ Riley et al.
DRUG METABOLISM AND DISPOSITION (2005)
A physiologically based, recirculatory model of the kinetics and dynamics of propofol in man
RN Upton et al.
ANESTHESIOLOGY (2005)
Prediction of drug disposition in infants and children by means of physiologically based pharmacokinetic (PBPK) modelling:: theophylline and midazolam as model drugs
S Björkman
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2005)
Physiologically based pharmacokinetic modeling 1: Predicting the tissue distribution of moderate-to-strong bases
T Rodgers et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2005)
Use of a physiologically based pharmacokinetic model to study the time to reach brain equilibrium: An experimental analysis of the role of blood-brain barrier permeability, plasma protein binding, and brain tissue binding
XR Liu et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Development and application of physiologically based pharmacokinetic-modeling tools to support drug discovery
C Lupfert et al.
CHEMISTRY & BIODIVERSITY (2005)
High-throughout determination of the free fraction of drugs strongly bound to plasma proteins
J Schuhmacher et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2004)
Prediction of cytochrome P450 3A inhibition by verapamil enantiomers and their metabolites
YH Wang et al.
DRUG METABOLISM AND DISPOSITION (2004)
Determination of volume of distribution at steady state with complete consideration of the kinetics of protein and tissue binding in linear pharmacokinetics
LM Berezhkovskiy
JOURNAL OF PHARMACEUTICAL SCIENCES (2004)
A physiological model for the estimation of the fraction dose absorbed in humans
S Willmann et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Prediction of human pharmacokinetic profile in animal scale up based on normalizing time course profiles
T Wajima et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2004)
A physiologically based approach for the estimation of recirculatory parameters
V Karalis et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
Recirculatory model of fentanyl disposition with the brain as the target organ
RN Upton et al.
BRITISH JOURNAL OF ANAESTHESIA (2004)
Impact of serum on clearance predictions obtained from suspensions and primary cultures of rat hepatocytes
N Blanchard et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2004)
The effects of dose staggering on metabolic drug-drug interactions
JS Yang et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2003)
Physiological approaches to the prediction of drug-drug interactions in study populations
JY Chien et al.
CURRENT DRUG METABOLISM (2003)
The conduct of in vitro and in vivo drug-drug interaction studies: A PhRMA perspective
TD Bjornsson et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2003)
Utility of physiologically based pharmacokinetic models to drug development and rational drug discovery candidate selection
FP Theil et al.
TOXICOLOGY LETTERS (2003)
Whole body pharmacokinetic models
I Nestorov
CLINICAL PHARMACOKINETICS (2003)
The influence of nonspecific microsomal binding on apparent intrinsic clearance, and its prediction from physicochemical properties
RP Austin et al.
DRUG METABOLISM AND DISPOSITION (2002)
Prediction of pharmacokinetics prior to in vivo studies.: II.: Generic physiologically based pharmacokinetic models of drug disposition
P Poulin et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2002)
Gastrointestinal transit and drug absorption
T Kimura et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2002)
Pharmacokinetic models of dermal absorption
KD McCarley et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2001)
Predicting the impact of physiological and biochemical processes on oral drug bioavailability
B Agoram et al.
ADVANCED DRUG DELIVERY REVIEWS (2001)
A whole-body physiologically based pharmacokinetic model incorporating dispersion concepts: Short and long time characteristics
RE Oliver et al.
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2001)
Dissolution testing as a prognostic tool for oral drug absorption:: Dissolution behavior of glibenclamide
R Löbenberg et al.
PHARMACEUTICAL RESEARCH (2000)
分享论文
